Form 4: SVV CEO Sells Shares Under Pre-Arranged Plan

Sentiment:

Insider Transaction Report


Savers Value Village CEO Mark T. Walsh sold 4,096 shares of common stock for $13.0174 per share after exercising options, pursuant to a pre-arranged 10b5-1 plan.

Summary

  • Mark T. Walsh, CEO and Director of Savers Value Village, Inc. (SVV), executed a transaction on September 11, 2025.
  • Walsh acquired 4,096 shares of common stock by exercising options at a price of $1.41 per share.
  • Concurrently, he disposed of 4,096 shares of common stock at a weighted average price of $13.0174 per share, with prices ranging from $13.00 to $13.04.
  • The sale was conducted under a Rule 10b5-1 trading plan, which was adopted by Walsh on May 19, 2025.
  • Following these transactions, Walsh beneficially owns 0 shares of common stock directly.
  • Walsh continues to beneficially own 2,104,710 derivative securities in the form of options, with an exercise price of $1.41 per share.
  • Approximately 37% of the remaining options are time-based, vesting in equal annual installments over five years starting October 7, 2020, and were fully vested on October 7, 2024.
  • Approximately 63% of the remaining options are performance-based, with 25% vesting upon the initial public offering and the remainder contingent on satisfaction of certain performance criteria, including stock price performance.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. While it involves insider selling, the transaction was pre-planned under a 10b5-1 plan, which typically reduces negative market perception. The executive also realized a substantial profit from the option exercise and sale, which is a positive for the individual.

Positives

  • The transaction was executed under a pre-arranged 10b5-1 plan, indicating a scheduled sale rather than a reaction to new information.
  • The executive realized a significant profit by exercising options at $1.41 and selling shares at an average of $13.0174.

Negatives

  • Insider selling, even if pre-planned, can sometimes be perceived negatively by some market participants, though the 10b5-1 plan mitigates this concern.

Risks

  • No specific risks are detailed in this Form 4 filing beyond the general market perception of insider selling, which is mitigated by the 10b5-1 plan.

Future Outlook

The filing indicates a pre-arranged sale under a 10b5-1 plan, which was adopted on May 19, 2025. This plan outlines future transactions and does not provide new forward-looking guidance on company performance. A significant portion of the remaining options (approximately 63%) are performance-based, with vesting contingent on satisfaction of certain performance criteria, including stock price performance, suggesting future incentives tied to company valuation.

Industry Context

This Form 4 filing details an insider transaction, which is a routine disclosure for publicly traded companies. It does not provide specific industry-wide insights but reflects standard executive compensation practices involving stock options and planned sales, common across various sectors for managing personal finances and diversifying holdings.

Stakeholder Impact

  • Shareholders: May view the insider sale with slight caution, though the 10b5-1 plan mitigates concerns about opportunistic selling. The executive's continued significant option holdings align interests with long-term stock performance.
  • Employees: No direct impact mentioned.

Key Dates

DateDescription
10/07/2019Original grant date of stock options under the Registrant's 2019 Management Incentive Plan.
10/07/2020Start date for substantially equal annual installments of vesting for time-based options.
10/07/2024Date when the October 7, 2019 stock option grant was fully vested.
05/19/2025Date the reporting person adopted the 10b5-1 Plan for the sale of equity securities.
09/11/2025Date of the reported transactions (exercise of options and sale of common stock).
09/15/2025Signature date of the reporting person's attorney-in-fact for the filing.
10/07/2029Expiration date of the derivative options.

Recommendation

hold

The transaction is a routine insider sale executed under a pre-arranged 10b5-1 plan, which typically does not signal new material information about the company's prospects. While the CEO sold shares, the sale was planned well in advance, and the executive retains a substantial number of options, aligning their interests with future stock performance. Therefore, this filing alone does not warrant a change in investment thesis, and a 'hold' recommendation is appropriate.

Keywords

Savers Value Village, SVV, Mark T. Walsh, Insider Trading, Form 4, 10b5-1 Plan, Stock Options, Executive Compensation, Share Sale

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.